Malignant melanoma in transplant patients: A case report and review of the literature

A. Nichole Sullivan, Elizabeth A. Bryant, Lawrence A. Mark

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

The clinical course and outcome of malignant melanoma (MM) are well-established for immunocompetent groups; however, they are not well-documented for immunosuppressed populations. Specifically, the influence of immunosuppression may result in poorer outcomes, especially in more advanced cases of melanoma. We report a 67-year-old woman who had previously undergone a kidney and pancreas transplant and presented with American Joint Committee on Cancer (AJCC) stage IIIA melanoma with subsequent rapid demise. As medicine advances with greater numbers of organ transplant recipients, a multi-institutional prospective study for this at-risk population would be greatly beneficial to help characterize the incidence, progression, and prognosis of melanoma in posttransplant immunosuppressed populations.

Original languageEnglish (US)
Pages (from-to)133-136
Number of pages4
JournalCutis
Volume89
Issue number3
StatePublished - Mar 1 2012

    Fingerprint

ASJC Scopus subject areas

  • Dermatology

Cite this